Log in

Vitalhub Stock Forecast, Price & News

-0.07 (-2.94 %)
(As of 09/18/2020 02:15 PM ET)
Today's Range
Now: C$2.31
50-Day Range
MA: C$1.97
52-Week Range
Now: C$2.31
Volume15,676 shs
Average Volume44,194 shs
Market CapitalizationC$67.54 million
P/E RatioN/A
Dividend YieldN/A
VitalHub Corp. develops and supports Web, mobile, electronic healthcare record solutions and blockchain technology to create disruptive software as a service based healthcare applications in Canada. The company is based in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.24 out of 5 stars

Industry, Sector and Symbol

Industry Health Information Services



Sales & Book Value

Annual SalesC$10.48 million
Cash FlowC$0.57 per share
Book ValueC$1.15 per share



Market CapC$67.54 million
Next Earnings Date11/19/2020 (Estimated)
OptionableNot Optionable
-0.07 (-2.94 %)
(As of 09/18/2020 02:15 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VHI News and Ratings via Email

Sign-up to receive the latest news and ratings for VHI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Vitalhub (CVE:VHI) Frequently Asked Questions

How has Vitalhub's stock been impacted by COVID-19 (Coronavirus)?

Vitalhub's stock was trading at C$1.46 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, VHI stock has increased by 58.2% and is now trading at C$2.31.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Vitalhub?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vitalhub in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Vitalhub

When is Vitalhub's next earnings date?

Vitalhub is scheduled to release its next quarterly earnings announcement on Thursday, November 19th 2020.
View our earnings forecast for Vitalhub

How were Vitalhub's earnings last quarter?

Vitalhub Corp (CVE:VHI) posted its earnings results on Tuesday, August, 11th. The company reported $0.01 EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.01) by $0.02. The company had revenue of $2.75 million for the quarter, compared to the consensus estimate of $2.50 million.
View Vitalhub's earnings history

What price target have analysts set for VHI?

1 analysts have issued 12-month price targets for Vitalhub's shares. Their forecasts range from C$3.00 to C$3.00. On average, they expect Vitalhub's share price to reach C$3.00 in the next year. This suggests a possible upside of 29.9% from the stock's current price.
View analysts' price targets for Vitalhub

Who are some of Vitalhub's key competitors?

What other stocks do shareholders of Vitalhub own?

Who are Vitalhub's key executives?

Vitalhub's management team includes the following people:
  • Mr. Daniel Matlow, Pres, CEO & Director (Age 56)
  • Mr. Brian Goffenberg, Exec. VP & CFO
  • Mr. Niels Tofting, Exec. VP of Bus. Devel. & Marketing

What is Vitalhub's stock symbol?

Vitalhub trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VHI."

How do I buy shares of Vitalhub?

Shares of VHI and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Vitalhub's stock price today?

One share of VHI stock can currently be purchased for approximately C$2.31.

How big of a company is Vitalhub?

Vitalhub has a market capitalization of C$67.54 million and generates C$10.48 million in revenue each year.

What is Vitalhub's official website?

The official website for Vitalhub is vitalhub.com.

How can I contact Vitalhub?

The company can be reached via phone at 416-699-0123.

This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.